Logan M. Langin

ORCID: 0000-0003-3917-2099

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A tailored Cln3Q352X mouse model for testing therapeutic interventions in CLN3 Batten disease”.

A tailored Cln3Q352X mouse model for testing therapeutic interventions in CLN3 Batten disease

Scientific Reports(2020)10.1038/s41598-020-67478-5

N/A

0.470DataRank · unranked

22 citations

Tyler B. Johnson, Attila Kovács, David A. Pearce, Jill M. Weimer, Logan M. Langin

AAV9 gene therapy restores lifespan and treats pathological and behavioral abnormalities in a mouse model of CLN8-Batten disease

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.05.079350

N/A

0.104DataRank · unranked

1 citations

Katherine A. White, Jacob T. Cain, Logan M. Langin, Melissa A. Pratt, Jon J. Brudvig +8 more

AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease

Molecular Therapy(2020)10.1016/j.ymthe.2020.09.033

N/A

0DataRank · unranked

43 citations

Katherine A. White, Jon J. Brudvig, Jacob T. Cain, Logan M. Langin, Melissa A. Pratt +8 more